Celltrion wins 294.9 bln-won drug substance supply deal from global firm
SEOUL, March 17 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutic...
📰 Original Source
Read full article at En →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.